CliffBio
small molecule

TIZANIDINE HYDROCHLORIDE

TIZANIDINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameTIZANIDINE HYDROCHLORIDE
Active ingredientTIZANIDINE HYDROCHLORIDE
StrengthEQ 4MG BASE
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 2004
Marketing statusRX

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.